These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26391571)

  • 1. Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases.
    Tian W; Epstein JI
    Hum Pathol; 2015 Dec; 46(12):1836-41. PubMed ID: 26391571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma.
    Watts KE; Montironi R; Mazzucchelli R; van der Kwast T; Osunkoya AO; Stephenson AJ; Hansel DE
    Urology; 2012 Aug; 80(2):361-6. PubMed ID: 22857755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.
    Kaymaz E; Ozer E; Unverdi H; Hucumenoglu S
    Indian J Pathol Microbiol; 2017; 60(4):510-514. PubMed ID: 29323063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.
    Jung M; Kim B; Moon KC
    Histopathology; 2019 Feb; 74(3):483-493. PubMed ID: 30286252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
    Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases.
    Amin A; Epstein JI
    Hum Pathol; 2012 Dec; 43(12):2124-8. PubMed ID: 22939957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
    Koyuncuer A
    Indian J Pathol Microbiol; 2013; 56(1):10-5. PubMed ID: 23924551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?
    Garbar C; Mascaux C
    Anal Quant Cytol Histol; 2011 Oct; 33(5):277-82. PubMed ID: 22611755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
    Holmäng S; Andius P; Hedelin H; Wester K; Busch C; Johansson SL
    J Urol; 2001 Apr; 165(4):1124-8; discussion 1128-30. PubMed ID: 11257652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.
    Mai KT; Flood TA; Williams P; Kos Z; Belanger EC
    Virchows Arch; 2013 Oct; 463(4):575-81. PubMed ID: 23913166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.